Literature DB >> 21959057

Development of an animal model for radiofrequency ablation of primary, virally induced hepatocellular carcinoma in the woodchuck.

Charles T Burke1, John M Cullen, Andrei State, Sashi Gadi, Kathy Wilber, Michael Rosenthal, Anna Bulysheva, Anthony Pease, Mathew A Mauro, Henry Fuchs.   

Abstract

PURPOSE: To develop a consistent and reproducible method in an animal model for studies of radiofrequency (RF) ablation of primary hepatocellular carcinoma (HCC).
MATERIALS AND METHODS: Fifteen woodchucks were inoculated with woodchuck hepatitis virus (WHV) to establish chronic infections. When serum γ-glutamyl transpeptidase levels became elevated, the animals were evaluated with ultrasound, and, in most cases, preoperative magnetic resonance (MR) imaging to confirm tumor development. Ultimately, RF ablation of tumors was performed by using a 1-cm probe with the animal submerged in a water bath for grounding. Ablation effectiveness was evaluated with contrast-enhanced MR imaging and gross and histopathologic analysis.
RESULTS: RF ablation was performed in 15 woodchucks. Modifications were made to the initial study design to adapt methodology for the woodchuck. The last 10 of these animals were treated with a standardized protocol using a 1-cm probe that produced a consistent area of tumor necrosis (mean size of ablation, 10.2 mm × 13.1 mm) and led to no complications.
CONCLUSIONS: A safe, reliable and consistent method was developed to study RF ablation of spontaneous primary HCC using chronically WHV-infected woodchucks, an animal model of hepatitis B virus-induced HCC.
Copyright © 2011 SIR. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21959057      PMCID: PMC3202064          DOI: 10.1016/j.jvir.2011.08.020

Source DB:  PubMed          Journal:  J Vasc Interv Radiol        ISSN: 1051-0443            Impact factor:   3.464


  14 in total

1.  Multiple probe radiofrequency ablation: pilot study in an animal model.

Authors:  Fred T Lee; Dieter Haemmerich; Andrew S Wright; David M Mahvi; Lisa A Sampson; John G Webster
Journal:  J Vasc Interv Radiol       Date:  2003-11       Impact factor: 3.464

2.  Hepatic ablation using radiofrequency electrocautery.

Authors:  J P McGahan; P D Browning; J M Brock; H Tesluk
Journal:  Invest Radiol       Date:  1990-03       Impact factor: 6.016

3.  Woodchuck hepatitis virus-induced carcinoma as a relevant natural model for therapy of human hepatoma.

Authors:  C Gouillat; D Manganas; F Zoulim; D Vitrey; G Saguier; M Guillaud; J F Ain; R Duque-Campos; C Jamard; M Praves; C Trepo
Journal:  J Hepatol       Date:  1997-06       Impact factor: 25.083

Review 4.  Hepatocellular carcinoma in the woodchuck model of hepatitis B virus infection.

Authors:  Bud C Tennant; Ilia A Toshkov; Simon F Peek; James R Jacob; Stephan Menne; William E Hornbuckle; Raymond D Schinazi; Brent E Korba; Paul J Cote; John L Gerin
Journal:  Gastroenterology       Date:  2004-11       Impact factor: 22.682

5.  Radio-frequency tissue ablation of the liver: effects of vascular occlusion on lesion diameter and biliary and portal damages in a pig model.

Authors:  A L Denys; T De Baere; C Mahe; J C Sabourin; A Sa Cunha; S Germain; A Roche
Journal:  Eur Radiol       Date:  2001       Impact factor: 5.315

6.  National Toxicology Program nomenclature for hepatoproliferative lesions of rats.

Authors:  R R Maronpot; C A Montgomery; G A Boorman; E E McConnell
Journal:  Toxicol Pathol       Date:  1986       Impact factor: 1.902

7.  Biliary lesions during radiofrequency ablation in liver. Study on the pig.

Authors:  F Marchal; D Elias; P Rauch; A Leroux; J Stinès; J L Verhaeghe; F Guillemin; J P Villemot
Journal:  Eur Surg Res       Date:  2004 Mar-Apr       Impact factor: 1.745

8.  Integration of woodchuck hepatitis and N-myc rearrangement determine size and histologic grade of hepatic tumors.

Authors:  James R Jacob; Agnes Sterczer; Ilia A Toshkov; Amy E Yeager; Brent E Korba; Paul J Cote; Marie-Annick Buendia; John L Gerin; Bud C Tennant
Journal:  Hepatology       Date:  2004-04       Impact factor: 17.425

9.  Enhanced in vivo adenovirus-mediated gene transfer to rat hepatocarcinomas by selective administration into the hepatic artery.

Authors:  R Gérolami; J Cardoso; M P Bralet; C A Cuenod; O Clément; P L Tran; C Bréchot
Journal:  Gene Ther       Date:  1998-07       Impact factor: 5.250

10.  Image-guided percutaneous chemical and radiofrequency tumor ablation in an animal model.

Authors:  Muneeb Ahmed; Joseph Weinstein; Zhengjun Liu; Karim S Afzal; Clare Horkan; Jonathan B Kruskal; S Nahum Goldberg
Journal:  J Vasc Interv Radiol       Date:  2003-08       Impact factor: 3.464

View more
  9 in total

1.  Transarterial Chemoembolization in a Woodchuck Model of Hepatocellular Carcinoma.

Authors:  William F Pritchard; David L Woods; Juan A Esparza-Trujillo; Matthew F Starost; Michal Mauda-Havakuk; Andrew S Mikhail; Ivane Bakhutashvili; Shelby Leonard; Elizabeth C Jones; Venkatesh Krishnasamy; John W Karanian; Bradford J Wood
Journal:  J Vasc Interv Radiol       Date:  2020-02-24       Impact factor: 3.464

2.  Segmental Transarterial Embolization in a Translational Rat Model of Hepatocellular Carcinoma.

Authors:  Terence P F Gade; Stephen J Hunt; Neil Harrison; Gregory J Nadolski; Charles Weber; Stephen Pickup; Emma E Furth; Mitchell D Schnall; Michael C Soulen; M Celeste Simon
Journal:  J Vasc Interv Radiol       Date:  2015-04-08       Impact factor: 3.464

3.  Woodchuck Hepatic Anatomy and Vascular Alterations Due to Hepatocellular Carcinoma with Angiographic Atlas of the Abdomen and Pelvis.

Authors:  Michal Mauda-Havakuk; Michael T Kassin; Andrew S Mikhail; Juan A Esparza-Trujillo; Ivane Bakhutashvili; David L Woods; Paul G Wakim; Matthew F Starost; John W Karanian; Bradford J Wood; William F Pritchard
Journal:  J Vasc Interv Radiol       Date:  2021-11-17       Impact factor: 3.464

Review 4.  Animal Models of Hepatocellular Carcinoma for Local-Regional Intraarterial Therapies.

Authors:  Vishnu M Chandra; Luke R Wilkins; David L Brautigan
Journal:  Radiol Imaging Cancer       Date:  2022-07

5.  AS30D model of hepatocellular carcinoma: tumorigenicity and preliminary characterization by imaging, histopathology, and immunohistochemistry.

Authors:  Scott M Thompson; Matthew R Callstrom; Bruce Knudsen; Jill L Anderson; Kim A Butters; Joseph P Grande; Lewis R Roberts; David A Woodrum
Journal:  Cardiovasc Intervent Radiol       Date:  2012-08-25       Impact factor: 2.740

6.  Electromagnetic Tracking and Optical Molecular Imaging Guidance for Liver Biopsy and Point-of-Care Tissue Assessment in Phantom and Woodchuck Hepatocellular Carcinoma.

Authors:  Quirina M B de Ruiter; Sheng Xu; Ming Li; William F Pritchard; Matthew F Starost; Armando Filie; Andrew S Mikhail; Michal Mauda-Havakuk; Juan A Esparza-Trujillo; Ivane Bakhutashvili; Pedram Heidari; Umar Mahmood; John W Karanian; Bradford J Wood
Journal:  Cardiovasc Intervent Radiol       Date:  2021-05-21       Impact factor: 2.797

Review 7.  The Oncopig Cancer Model: An Innovative Large Animal Translational Oncology Platform.

Authors:  Kyle M Schachtschneider; Regina M Schwind; Jordan Newson; Nickolas Kinachtchouk; Mark Rizko; Nasya Mendoza-Elias; Paul Grippo; Daniel R Principe; Alex Park; Nana H Overgaard; Gregers Jungersen; Kelly D Garcia; Ajay V Maker; Laurie A Rund; Howard Ozer; Ron C Gaba; Lawrence B Schook
Journal:  Front Oncol       Date:  2017-08-23       Impact factor: 6.244

8.  Imaging, Pathology, and Immune Correlates in the Woodchuck Hepatic Tumor Model.

Authors:  Michal Mauda-Havakuk; Andrew S Mikhail; Matthew F Starost; Elizabeth C Jones; Baktiar Karim; David E Kleiner; Ari Partanen; Juan A Esparza-Trujillo; Ivane Bakhutashvili; Paul G Wakim; Michael T Kassin; Andrew L Lewis; John W Karanian; Bradford J Wood; William F Pritchard
Journal:  J Hepatocell Carcinoma       Date:  2021-03-09

9.  Development of a radiofrequency ablation platform in a clinically relevant murine model of hepatocellular cancer.

Authors:  Xiaoqiang Qi; Guangfu Li; Dai Liu; Anjan Motamarry; Xiangwei Huang; A Marissa Wolfe; Kristi L Helke; Dieter Haemmerich; Kevin F Staveley-O'Carroll; Eric T Kimchi
Journal:  Cancer Biol Ther       Date:  2015       Impact factor: 4.875

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.